Ko G T, Chan J C, Woo J, Lau E, Yeung V T, Chow C C, Cockram C S
Department of Medicine, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Ann Clin Biochem. 1998 Jan;35 ( Pt 1):62-7. doi: 10.1177/000456329803500107.
We examined the reproducibility of oral glucose tolerance tests (OGTT) using the World Health Organization criterion in 212 Chinese subjects (male 149, female 63) who underwent two 75 g OGTTs within a 6-week period. The overall reproducibility was 65.6% (139/212) of which 74 subjects had normal glucose tolerance, 24 had diabetes and 41 had impaired glucose tolerance (IGT) on two occasions. The subjects were divided into three groups [group 1: normal OGTTs on both occasions (n = 74); group 2: one abnormal OGTT (either diabetes or IGT (n = 51); group 3: 2 abnormal OGTTs (n = 87)]. Subjects in group 1 were younger, had lower blood pressure, body mass index (BMI), waist-to-hip ratio (WHR), fasting and 2 h plasma insulin levels, triglyceride, very-low density lipoprotein and apolipoprotein-B concentrations than both groups 2 and 3. Group 2 had similar characteristics as group 3 except for a lower glycated haemoglobin (HbA1c), fasting and 2 h plasma glucose during the two OGTTs. With receiver operating characteristic curve (ROC) analysis, a HbA1c of 5.3% gave an optimal sensitivity of 70.7% and specificity of 74.3% to predict diabetes as defined by a 2 h plasma glucose value > or = 11.1 mmol/L in the first OGTT. Of the 212 subjects, 73 had HbA1c > or = 5.3%. The reproducibility of OGTT was 56.2% for these 73 subjects. With ROC analysis, a BMI of 25 kg/m2 gave an optimal sensitivity of 53.7% and specificity of 56.7% to predict diabetes. For the 36 subjects with BMI > or = 25 kg/m2, the reproducibility of OGTT was 58.3%. Similarly, for the 140 subjects with WHR > or = 0.9, the reproducibility of OGTT was 57.9%. These findings confirmed the poor reproducibility of OGTT which was not improved even amongst subjects with high HbA1c, BMI or WHR. Furthermore, subjects with one abnormal OGTT, whether reproducible or not, had a higher cardiovascular risk profile compared to subjects who had two normal OGTTs.
我们采用世界卫生组织标准,对212名中国受试者(男性149名,女性63名)进行了口服葡萄糖耐量试验(OGTT)的重复性研究,这些受试者在6周内接受了两次75克OGTT检测。总体重复性为65.6%(139/212),其中74名受试者两次检测时糖耐量正常,24名患有糖尿病,41名糖耐量受损(IGT)。受试者被分为三组[第1组:两次OGTT均正常(n = 74);第2组:一次OGTT异常(糖尿病或IGT,n = 51);第3组:两次OGTT异常(n = 87)]。第1组受试者比第2组和第3组更年轻,血压、体重指数(BMI)、腰臀比(WHR)、空腹及餐后2小时血浆胰岛素水平、甘油三酯、极低密度脂蛋白和载脂蛋白B浓度更低。第2组与第3组具有相似特征,只是糖化血红蛋白(HbA1c)、两次OGTT期间的空腹及餐后2小时血糖较低。通过受试者工作特征曲线(ROC)分析,HbA1c为5.3%时,预测首次OGTT中2小时血浆葡萄糖值≥11.1 mmol/L定义的糖尿病的最佳灵敏度为70.7%,特异性为74.3%。在212名受试者中,73名HbA1c≥5.3%。这73名受试者OGTT的重复性为56.2%。通过ROC分析,BMI为25 kg/m²时,预测糖尿病的最佳灵敏度为53.7%,特异性为56.7%。对于36名BMI≥25 kg/m²的受试者,OGTT的重复性为58.3%。同样,对于140名WHR≥0.9的受试者,OGTT的重复性为57.9%。这些发现证实了OGTT的重复性较差,即使在HbA1c、BMI或WHR较高人群中也未得到改善。此外,与两次OGTT均正常的受试者相比,一次OGTT异常的受试者,无论是否可重复,其心血管风险状况更高。